rs4150342

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000123.4(ERCC5):​c.2636A>G​(p.Asn879Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,614,222 control chromosomes in the GnomAD database, including 134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0093 ( 13 hom., cov: 32)
Exomes 𝑓: 0.012 ( 121 hom. )

Consequence

ERCC5
NM_000123.4 missense

Scores

1
3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 9.21

Publications

23 publications found
Variant links:
Genes affected
ERCC5 (HGNC:3437): (ERCC excision repair 5, endonuclease) This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011]
BIVM-ERCC5 (HGNC:43690): (BIVM-ERCC5 readthrough) This locus represents naturally occurring read-through transcription between the neighboring BIVM (basic, immunoglobulin-like variable motif containing) and ERCC5 (excision repair cross-complementing rodent repair deficiency, complementation group 5) genes on chromosome 13. The read-through transcript encodes a fusion protein that shares sequence identity with the products of each individual gene. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009051204).
BP6
Variant 13-102868215-A-G is Benign according to our data. Variant chr13-102868215-A-G is described in ClinVar as Benign. ClinVar VariationId is 134162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00933 (1422/152358) while in subpopulation AMR AF = 0.018 (276/15302). AF 95% confidence interval is 0.0163. There are 13 homozygotes in GnomAd4. There are 725 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC5NM_000123.4 linkc.2636A>G p.Asn879Ser missense_variant Exon 12 of 15 ENST00000652225.2 NP_000114.3
BIVM-ERCC5NM_001204425.2 linkc.3998A>G p.Asn1333Ser missense_variant Exon 20 of 23 NP_001191354.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC5ENST00000652225.2 linkc.2636A>G p.Asn879Ser missense_variant Exon 12 of 15 NM_000123.4 ENSP00000498881.2
BIVM-ERCC5ENST00000639435.1 linkc.3998A>G p.Asn1333Ser missense_variant Exon 22 of 25 5 ENSP00000491742.1
BIVM-ERCC5ENST00000639132.1 linkc.3311A>G p.Asn1104Ser missense_variant Exon 21 of 24 5 ENSP00000492684.1

Frequencies

GnomAD3 genomes
AF:
0.00933
AC:
1421
AN:
152240
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00236
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0181
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00475
Gnomad FIN
AF:
0.00828
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0129
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00987
AC:
2482
AN:
251464
AF XY:
0.00991
show subpopulations
Gnomad AFR exome
AF:
0.00215
Gnomad AMR exome
AF:
0.0106
Gnomad ASJ exome
AF:
0.00933
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00859
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.0118
AC:
17314
AN:
1461864
Hom.:
121
Cov.:
31
AF XY:
0.0117
AC XY:
8479
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00221
AC:
74
AN:
33480
American (AMR)
AF:
0.0115
AC:
515
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
256
AN:
26132
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39690
South Asian (SAS)
AF:
0.00460
AC:
397
AN:
86258
European-Finnish (FIN)
AF:
0.00760
AC:
406
AN:
53418
Middle Eastern (MID)
AF:
0.0191
AC:
110
AN:
5768
European-Non Finnish (NFE)
AF:
0.0134
AC:
14874
AN:
1112000
Other (OTH)
AF:
0.0112
AC:
676
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
930
1859
2789
3718
4648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00933
AC:
1422
AN:
152358
Hom.:
13
Cov.:
32
AF XY:
0.00973
AC XY:
725
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00236
AC:
98
AN:
41590
American (AMR)
AF:
0.0180
AC:
276
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00865
AC:
30
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00496
AC:
24
AN:
4834
European-Finnish (FIN)
AF:
0.00828
AC:
88
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0129
AC:
879
AN:
68036
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
74
148
221
295
369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0120
Hom.:
60
Bravo
AF:
0.00966
TwinsUK
AF:
0.0156
AC:
58
ALSPAC
AF:
0.0122
AC:
47
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.0140
AC:
120
ExAC
AF:
0.00951
AC:
1155
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0133
EpiControl
AF:
0.0151

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
May 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 11841555, 24728327) -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ERCC5 p.Asn879Ser variant was identified in dbSNP (ID: rs4150342) and ClinVar (submitted by ITMI with no classification) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 2751 of 282866 chromosomes (15 homozygous) at a frequency of 0.009725 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 1776 of 129182 chromosomes (freq: 0.01375), Latino in 384 of 35438 chromosomes (freq: 0.01084), Other in 77 of 7224 chromosomes (freq: 0.01066), Ashkenazi Jewish in 95 of 10370 chromosomes (freq: 0.009161), European (Finnish) in 218 of 25122 chromosomes (freq: 0.008678), South Asian in 143 of 30616 chromosomes (freq: 0.004671), African in 56 of 24964 chromosomes (freq: 0.002243), and East Asian in 2 of 19950 chromosomes (freq: 0.0001). The variant was identified in a patient with Xeroderma Pigmentosum who also carried multiple other ERCC5 variants, therefore the N879S variant was not expected to have functional significance (Lalle_2002_PMID:11841555). The p.Asn879 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ERCC5: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Xeroderma pigmentosum, group G Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
.;.;.;T;.
Eigen
Benign
-0.013
Eigen_PC
Benign
0.17
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D;.;D;D
MetaRNN
Benign
0.0091
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
.;.;.;L;.
PhyloP100
9.2
PROVEAN
Uncertain
-2.6
.;.;.;D;N
REVEL
Benign
0.23
Sift
Benign
0.32
.;.;.;T;T
Sift4G
Benign
0.28
.;.;.;T;T
Polyphen
0.52
.;.;.;P;.
Vest4
0.59, 0.67
MVP
0.66
MPC
0.50
ClinPred
0.021
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.34
gMVP
0.40
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4150342; hg19: chr13-103520565; API